ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,209, issued on July 7, was assigned to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (Chapel Hill, N.C.).
"Compositions and methods for the selective detection of tumor-derived viral DNA" was invented by Gaorav Gupta (Chapel Hill, N.C.), Bhishamjit S. Chera (Chapel Hill, N.C.) and Sunil Kumar (Chapel Hill, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and compositions of modified oligonucleotide primer and probe combinations, structurally modified with locked nucleic acids, quenchers, and dyes, effective to detect tumor-derived Human Papilloma Virus (HPV) and tumor-derived Epstein-Barr virus (EBV) and, ...